Retour
15
Fourchette du Jour
98,44 €
100,97 €
Fourchette 52 Semaines
47,48 €
107,90 €
Volume
101 206
Moyenne 50J / 200J
100,42 €
/
81,20 €
Clôture Précédente
99,20 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 57,4 | 0,3 |
| P/B | 13,6 | 2,9 |
| ROE % | 24,8 | 3,7 |
| Net Margin % | 26,8 | 3,8 |
| Rev Growth 5Y % | 19,0 | 10,0 |
| D/E | 0,0 | 0,2 |
Objectif de Cours des Analystes
Hold
120,00 €
+18.8%
P/E Prévisionnel
47,7
BPA Prévisionnel
2,08 €
Croissance BPA (est.)
+0,0%
CA Est.
92 M
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2027 |
2,32 €
2,30 € – 2,34 €
|
100 M | 1 |
| FY2026 |
2,08 €
2,07 € – 2,09 €
|
92 M | 1 |
Points Clés
Revenue grew 18,99% annually over 5 years — strong growth
Earnings grew 16,88% over the past year
ROE of 24,78% indicates high profitability
Net margin of 26,82% shows strong profitability
Debt/Equity of 0,00 — conservative balance sheet
Generating 17,18M in free cash flow
Croissance
Revenue Growth (5Y)
18,99%
Revenue (1Y)14,43%
Earnings (1Y)16,88%
FCF Growth (3Y)77,43%
Qualité
Return on Equity
24,78%
ROIC20,73%
Net Margin26,82%
Op. Margin31,20%
Sécurité
Debt / Equity
0,00
Current Ratio7,98
Interest Coverage0,00
Valorisation
P/E Ratio
57,41
P/B Ratio13,64
EV/EBITDA47,40
Dividend Yield0,01%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 14,43% | Revenue Growth (3Y) | 13,07% |
| Earnings Growth (1Y) | 16,88% | Earnings Growth (3Y) | 14,35% |
| Revenue Growth (5Y) | 18,99% | Earnings Growth (5Y) | 24,60% |
| Profitability | |||
| Revenue (TTM) | 83,81M | Net Income (TTM) | 22,48M |
| ROE | 24,78% | ROA | 20,67% |
| Gross Margin | 76,75% | Operating Margin | 31,20% |
| Net Margin | 26,82% | Free Cash Flow (TTM) | 17,18M |
| ROIC | 20,73% | FCF Growth (3Y) | 77,43% |
| Safety | |||
| Debt / Equity | 0,00 | Current Ratio | 7,98 |
| Interest Coverage | 0,00 | Dividend Yield | 0,01% |
| Valuation | |||
| P/E Ratio | 57,41 | P/B Ratio | 13,64 |
| P/S Ratio | 15,40 | PEG Ratio | 3,35 |
| EV/EBITDA | 47,40 | Dividend Yield | 0,01% |
| Market Cap | 1,29B | Enterprise Value | 1,24B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 83,81M | 73,24M | 65,56M | 53,30M | 41,81M |
| Net Income | 22,48M | 19,23M | 17,19M | 12,83M | 9,33M |
| EPS (Diluted) | 1,75 | 1,50 | 1,35 | 1,02 | 0,74 |
| Gross Profit | 64,32M | 56,35M | 50,16M | 41,28M | 32,05M |
| Operating Income | 26,15M | 21,96M | 20,04M | 15,63M | 9,82M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 108,78M | 98,33M | 92,16M | 85,51M | 82,88M |
| Total Liabilities | 14,16M | 11,51M | 20,74M | 11,84M | 10,71M |
| Shareholders' Equity | 94,62M | 86,82M | 71,42M | 73,67M | 72,17M |
| Total Debt | 0,0 | 154 688,0 | 2,04M | 2,21M | 2,48M |
| Cash & Equivalents | 51,16M | 52,23M | 49,76M | 57,96M | 62,00M |
| Current Assets | 81,20M | 75,24M | 76,00M | 77,49M | 76,24M |
| Current Liabilities | 10,18M | 8,51M | 16,33M | 8,55M | 6,82M |
Scores de Stratégies
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
#151 of 157
Activité Récente
Entré
Growth Investing (Philip Fisher)
Mar 24, 2026